Page last updated: 2024-08-26

peptide elongation factor 2 and Hairy Cell Leukemia

peptide elongation factor 2 has been researched along with Hairy Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kreitman, RJ; Pastan, I	1

Reviews

1 review(s) available for peptide elongation factor 2 and Hairy Cell Leukemia

Article	Year
Immunoconjugates in the management of hairy cell leukemia. Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Toxins; Cladribine; Clinical Trials as Topic; Exotoxins; Humans; Immunoconjugates; Leukemia, Hairy Cell; Mutation; Neoplasm, Residual; Pentostatin; Peptide Elongation Factor 2; Proto-Oncogene Proteins B-raf; Remission Induction; Survival Analysis	2015

Article

Year

Immunoconjugates in the management of hairy cell leukemia.

Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:4

Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Toxins; Cladribine; Clinical Trials as Topic; Exotoxins; Humans; Immunoconjugates; Leukemia, Hairy Cell; Mutation; Neoplasm, Residual; Pentostatin; Peptide Elongation Factor 2; Proto-Oncogene Proteins B-raf; Remission Induction; Survival Analysis

2015